US-based contract research organisation (CRO) PhenoVista Biosciences has entered a collaboration with NETRI, the France-based manufacturer of microfluidic devices for high-throughput screening ...

This partnership will combine PhenoVista’s extensive experience in developing biologically complex, in vitro models for high-content imaging with NETRI’s expertise in creating powerful ...

For the past 6 years, NETRI has been focused on addressing neurological disorders such as Alzheimer's, Parkinson's and ALS diseases by using its NeuroFluidics™ 2D devices coupled with Multi ...